The total value of the global surgical sutures market was USD 4.1 billion in 2021, and it will rise at a growth rate of above 5.9% shortly, reaching USD 6.8 billion by 2030, according to P&S Intelligence. This development can be credited to the growing count of medical procedures and the growing occurrence of chronic illnesses throughout the globe.
In recent years, absorbable sutures led the industry, with a market share of above 52%, and the same is also estimated to be in the leading position throughout the forecast period. This is mainly because of its timings, as it takes less time and reduces the count of patient visits to hospitals.
Internal operations regularly use absorbable sutures because they naturally and securely break in the body. Hydrolytic, proteolytic, and enzymatic devices are utilized to degrade these sutures. Reliant on the material used for the process, the breakdown procedure characteristically takes 9 days to 8 weeks. Different materials, polyglycolic acid, including catgut, polylactic acid, and polydioxanone, are utilized to make absorbable sutures.
In 2021, the cardiovascular surgery category had the largest surgical sutures market share, approximately 30.0%, because of the rising occurrence of cardiovascular illnesses. Cardiovascular operations, such as heart transplantation operations, are undertaken to cure difficulties of valvar heart illnesses, ischemic heart illnesses, and congenital heart illnesses.
Surgical procedures involving cardiovascular systems are the most complex and high-risk, necessitating sutures of the highest quality and suitability. An increase in the number of patients with heart disorders leads to a rise in the usage of cardiovascular surgeries, boosting the demand for sutures in the market.
In recent years, the North American region dominated the industry by generating the highest revenue share, of over 40%. This can be credited to the growing elderly populace, the growing count of road accidents, the rising cases of obesity and diabetes, and the growing burn cases in the continent.
Furthermore, the augmented requirement for improved surgical techniques and products, including biocompatible surgical sutures with antimicrobial coatings, is boosting the development of the industry in North America.
Hence, the growing count of medical procedures and the growing occurrence of chronic illnesses throughout the globe are the major factors propelling the surgical sutures market.